A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Aprobarbital
Human interferon omega-1
The risk or severity of bleeding can be increased when Edoxaban is combined with Human interferon omega-1.
Aprobarbital
Interferon alfa
The risk or severity of bleeding can be increased when Edoxaban is combined with Interferon alfa.
Aprobarbital
Trabectedin
The risk or severity of bleeding can be increased when Edoxaban is combined with Trabectedin.
Aprobarbital
Thiotepa
The risk or severity of bleeding can be increased when Edoxaban is combined with Thiotepa.
Aprobarbital
Vorinostat
The risk or severity of bleeding can be increased when Edoxaban is combined with Vorinostat.
Aprobarbital
Protocatechualdehyde
The risk or severity of bleeding can be increased when Edoxaban is combined with Protocatechualdehyde.
Aprobarbital
Brofaromine
The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Edoxaban.
Aprobarbital
Harmaline
The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Edoxaban.
Aprobarbital
Caroxazone
The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Edoxaban.
Aprobarbital
Safrazine
The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Edoxaban.
Aprobarbital
Pivhydrazine
The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Edoxaban.
Aprobarbital
Phenoxypropazine
The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Edoxaban.
Aprobarbital
Pheniprazine
The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Edoxaban.
Aprobarbital
Octamoxin
The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Edoxaban.
Aprobarbital
Mebanazine
The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Edoxaban.
Aprobarbital
Benmoxin
The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Edoxaban.
Aprobarbital
Toloxatone
The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Edoxaban.
Aprobarbital
Pirlindole
The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Edoxaban.
Aprobarbital
Hydracarbazine
The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Edoxaban.
Aprobarbital
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Edoxaban.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3